• Bloomberg


Anthony Fauci, the United States’ top infectious disease expert, highlighted how COVID-19 disproportionately sickens people of color, and said they must be strongly represented in the race to find a vaccine.

Fauci, who heads the National Institute for Allergy and Infectious Diseases, said in an interview at the Bloomberg Equality Summit that people of color often hold essential jobs that don’t allow them to work from home. At the same time, they have higher prevalence of conditions including diabetes, hypertension and obesity.

It’s a toxic combination that’s translated into higher COVID-19 hospitalization rates than the population at large, according to Fauci.

“There’s almost a double whammy on the minority populations,” he said.

Vaccine research also must recruit African-Americans, Latinos and other minorities to participate in late-stage vaccine trials, he said. There’s been progress with Latinos, according to Fauci, but “still, we have to do much, much better with the relative percentage of African Americans that are in the trial.”

When the shots are shown to be safe and effective, “we want to be able to say with confidence that they are safe and effective in all demographic groups,” Fauci said “You can make an assumption that they are, but we want to prove it.”

Once a vaccine is available, minorities will likely be in a priority group to receive it, he said. And because the shots were paid for by the U.S. government, they will be available for free, he added.

Though there may be costs to administer a vaccine, “that should not be something that gets in the way of poor people receiving it,” Fauci said.

Biggest challenge

In the interview, Fauci called the pandemic the biggest challenge he has seen in the four decades he’s been in his post, rivaled only by the HIV/AIDs crisis.

“When you talk about the concentrated explosion of a pandemic that essentially can involve virtually anybody and everybody on the planet,” he said, “the answer to your question is, yes, this is the most difficult thing we have faced in a very constrained period of time.”

Fauci also sketched out a realistic timeline for a vaccine during his interview, and talked about safeguards that should insulate the vaccine approval process from political pressure. Here’s what he had to say.

Vaccine timing

Fauci said that while it’s “aspirational” to have all Americans vaccinated by April of next year, it’s more likely to happen toward the middle to the end of 2021.

Manufacturing and the logistics of vaccinating people are considerations. There will likely be tens of millions of vaccine doses available by the end of the year and in the first quarter, and hundreds of millions by the end of the first quarter, Fauci said.

Then people have to actually receive a vaccine, and some experimental candidates require two shots. Moderna Inc.’s product, for instance, administers a prime and then a boost 28 days later, Fauci noted.

But he said he’s “reasonably confident” that coronavirus vaccines will start to become available much earlier, by November or December of this year. That could happen either through a formal approval by the U.S. Food and Drug Administration or an emergency clearance, according to Fauci.

During the interview, Fauci also sketched out a realistic timeline for a vaccine during his interview, and talked about safeguards that should insulate the vaccine approval process from political pressure. Here’s what he had to say.

Political pressure

The quest for coronavirus vaccines is taking place in a U.S. presidential election year, as the public-health crisis — and the ensuing economic disaster — have become a major issue for voters.

That’s driven fears about political pressure hastening an approval, especially as President Donald Trump himself has presented a rosier view of when a vaccine could be widely available than his own health officials.

“There is certainly a lot of talk and concern about politicization of the process of approval,” Fauci said. “But as I always point out to people, there are so many levels of checkpoints to mitigate against political interference with that.”

Chief among those safeguards is an independent data and safety monitoring board that analyzes vaccine data, safety and effectiveness, he said. Vaccine results will also eventually become public. And advisory committees to the FDA will play a role, as will the FDA itself, which has said it will not let politics interfere with its decision on a vaccine.

“So I’m going to take them for their word,” Fauci said.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.